Intellia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:38I Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Oct 24	Sell€34,634	Michael Dube	Individual	2,012	€17.21
01 Jul 24	Sell€8,661	Eliana Clark	Individual	405	€21.38
04 Mar 24	Sell€18,376	Eliana Clark	Individual	605	€30.37
04 Mar 24	Sell€69,769	James Basta	Individual	2,297	€30.37
03 Jan 24	Sell€104,645	Derek Hicks	Individual	3,877	€26.99
03 Jan 24	Sell€144,808	Glenn Goddard	Individual	5,365	€26.99
03 Jan 24	Sell€149,316	Laura Sepp-Lorenzino	Individual	5,532	€26.99
03 Jan 24	Sell€157,710	David Lebwohl	Individual	5,843	€26.99
03 Jan 24	Sell€518,853	John Leonard	Individual	19,223	€26.99
03 Jan 24	Sell€102,702	James Basta	Individual	3,805	€26.99
03 Jan 24	Sell€124,561	Eliana Clark	Individual	4,608	€27.60

Insider Trading Volume

Insider Buying: 38I insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 38I?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,281,644	1.26%
General Public	5,894,604	5.79%
Institutions	94,672,324	93%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.7%.

Top Shareholders

Top 25 shareholders own 73.75% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12%	ARK Investment Management LLC	12,255,440	€143.5m	5.69%	1.07%
9.6%	BlackRock, Inc.	9,772,742	€114.4m	1.82%	no data
9.45%	The Vanguard Group, Inc.	9,627,804	€112.7m	5.8%	no data
6.18%	Nikko Asset Management Co., Ltd.	6,297,796	€73.7m	93.3%	0.03%
5.05%	State Street Global Advisors, Inc.	5,143,534	€60.2m	17.9%	no data
4.86%	Deep Track Capital, LP	4,950,000	€57.9m	3.13%	1.9%
2.69%	Federated Hermes, Inc.	2,740,765	€32.1m	19.1%	0.08%
2.3%	Geode Capital Management, LLC	2,343,310	€27.4m	2.15%	no data
2.3%	FMR LLC	2,337,596	€27.4m	4.93%	no data
2.15%	AllianceBernstein L.P.	2,193,787	€25.7m	23.1%	0.01%
2.01%	Contrarius Investment Management Ltd.	2,047,218	€24.0m	6.88%	1.27%
1.96%	Casdin Capital, LLC	2,000,000	€23.4m	0%	1.6%
1.56%	Morgan Stanley, Investment Banking and Brokerage Investments	1,593,744	€18.7m	-0.13%	no data
1.42%	Dimensional Fund Advisors LP	1,447,250	€16.9m	9.26%	no data
1.37%	Pictet Asset Management Limited	1,394,911	€16.3m	87.5%	0.01%
1.06%	Himension Capital (Singapore) Pte Ltd	1,075,711	€12.6m	4.44%	0.92%
1.01%	Two Sigma Advisers, LP	1,027,617	€12.0m	33.5%	0.03%
0.97%	Citadel Advisors LLC	989,439	€11.6m	29.7%	0.01%
0.96%	Two Sigma Investments, LP	980,380	€11.5m	18.2%	0.03%
0.85%	Northern Trust Global Investments	866,290	€10.1m	3.7%	no data
0.82%	John Leonard	830,546	€9.7m	0%	no data
0.81%	Charles Schwab Investment Management, Inc.	827,545	€9.7m	4.77%	no data
0.8%	Chevy Chase Trust Company	811,033	€9.5m	-22.2%	0.03%
0.79%	Morgan Stanley Investment Management Inc.	809,480	€9.5m	43.4%	0.01%
0.74%	Balyasny Asset Management L.P.	749,861	€8.8m	116%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 02:34
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Intellia Therapeutics, Inc. is covered by 44 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Brian Skorney	Baird
Jack Allen	Baird
Huidong Wang	Barclays